Back to Search Start Over

Lymph Node Staging and Treatment in Pediatric Patients With Soft Tissue Sarcomas: A Consensus Opinion From the Children's Oncology Group, European paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe.

Authors :
Terwisscha van Scheltinga S
Schoot RA
Routh JC
Seitz G
Kao SC
de Keizer B
Shulkin B
Ewijk RV
McCarville B
Casey D
Allen-Rhoades W
Mercolini F
Merks H
Orbach D
Kapadia T
Walterhouse DO
Davila Fajardo R
Hiemcke-Jiwa L
Franzius C
De Corti F
Tang V
Metts J
Oberoi S
Vokuhl C
Dasgupta R
Birz S
Rodeberg D
Source :
Pediatric blood & cancer [Pediatr Blood Cancer] 2025 Apr; Vol. 72 (4), pp. e31538. Date of Electronic Publication: 2025 Jan 23.
Publication Year :
2025

Abstract

Accurate staging of nodal involvement in pediatric sarcoma patients is important to determine correct systemic and local therapy, with the goal to reduce subsequent recurrences. However, differences in lymph node staging strategies, definitions, and treatment protocols between the Children's Oncology Group (COG), European paediatric Soft tissue sarcoma Study Group (EpSSG), and the Cooperative Weichteilsarkom Studiengruppe (CWS) complicate comparisons. In this article, we aim to establish internationally recognized recommendations for lymph node assessment and treatment of children and adolescents diagnosed with rhabdomyosarcoma (RMS) and non-rhabdomyosarcoma soft tissue sarcoma (NRSTS) according to the Consensus Conference Standard Operating Procedure methodology.<br /> (© 2025 Wiley Periodicals LLC.)

Details

Language :
English
ISSN :
1545-5017
Volume :
72
Issue :
4
Database :
MEDLINE
Journal :
Pediatric blood & cancer
Publication Type :
Academic Journal
Accession number :
39844722
Full Text :
https://doi.org/10.1002/pbc.31538